Nonsteroidal Anti-inflammatory Drugs and Alzheimer Disease
- 4 June 2003
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 289 (21) , 2865-2867
- https://doi.org/10.1001/jama.289.21.2865
Abstract
In this issue of THE JOURNAL, Aisen and colleagues from the Alzheimer's Disease Cooperative Study (ADCS) report the results of a 1-year double-blind, placebo-Keywords
This publication has 23 references indexed in Scilit:
- Nonsteroidal Anti-Inflammatory Drug Use and the Risk for Alzheimer???s DiseaseDrugs, 2003
- Pharmacology and potential therapeutic applications of nitric oxide‐releasing non‐steroidal anti‐inflammatory and related nitric oxide‐donating drugsBritish Journal of Pharmacology, 2002
- Double placebo design in a prevention trial for Alzheimer's diseaseControlled Clinical Trials, 2002
- Selective Cyclo-Oxygenase-2 Inhibitors and Myocardial InfarctionDrug Safety, 2002
- Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H2 synthases by ibuprofen, naproxen, and indomethacinBiochemical Pharmacology, 2001
- Inflammation, autotoxicity and Alzheimer diseaseNeurobiology of Aging, 2001
- A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activityNature, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Cyclo-Oxygenase-2 InhibitorsDrugs & Aging, 2000
- Diagnosis of Alzheimer's DiseaseArchives of Neurology, 1985